Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruitao Lin

Showing results (51-60 of 96) with videos related to

Pageof 10
Sort By:
Contemporary Clinical Trials Communications|July 11, 2022
An overview of the BOIN design and its current extensions for novel early-phase oncology trialsRevathi Ananthakrishnan, Ruitao Lin, Chunsheng He, et al.
Plos One|August 7, 2015
Inter-Ethnic/Racial Facial Variations: A Systematic Review and Bayesian Meta-Analysis of Photogrammetric StudiesYi Feng Wen, Hai Ming Wong, Ruitao Lin, et al.
Statistics in Medicine|April 20, 2026
BAR12: Bayesian Autoregressive Phase 1-2 Design for Cell Therapy Trials With Manufacturing ChangesCheng-Han Yang, Peter F Thall, David Marin, et al.
The Annals of Applied Statistics|November 4, 2022
BAYESIAN HIERARCHICAL RANDOM-EFFECTS META-ANALYSIS AND DESIGN OF PHASE I CLINICAL TRIALSRuitao Lin, Haolun Shi, Guosheng Yin, et al.
Statistics in Medicine|January 31, 2022
TITE-BOIN12: A Bayesian phase I/II trial design to find the optimal biological dose with late-onset toxicity and efficacyYanhong Zhou, Ruitao Lin, J Jack Lee, et al.
Frontiers in Oncology|June 20, 2019
Trends and Patterns of Disparities in Burden of Lung Cancer in the United States, 1974-2015Yu Jie Zhong, Yi Feng Wen, Hai Ming Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2023
Novel Clinical Trial Designs with Dose Optimization to Improve Long-term OutcomesPeter F Thall, Yong Zang, Andrew G Chapple, et al.
Statistics in Medicine|May 20, 2025
TODO: A Triple-Outcome Double-Criterion Optimal Design for Dose Monitoring-and-Optimization in Multi-Dose Randomized TrialsJingyi Zhang, Heng Zhou, Nolan A Wages, et al.
Journal of Hematology & Oncology|June 10, 2021
The global, regional, and national burden of cancer among adolescents and young adults in 204 countries and territories, 1990-2019: a population-based studyYi Feng Wen, Meng Xuan Chen, Guosheng Yin, et al.
Joint Commission Journal on Quality and Patient Safety|May 22, 2026
Association of Timing of Psychiatry Consultation and Length of Stay and Length of Stay Index in Hospitalized Patients with Cancer: Risk-Adjusted OutcomesDeepti Chopra, Noman Ali, Kodwo Dickson, et al.
Pageof 10

Showing results (51-60 of 96) with videos related to

Sort By:
Pageof 10
Contemporary Clinical Trials Communications|July 11, 2022
An overview of the BOIN design and its current extensions for novel early-phase oncology trialsRevathi Ananthakrishnan, Ruitao Lin, Chunsheng He, et al.
Plos One|August 7, 2015
Inter-Ethnic/Racial Facial Variations: A Systematic Review and Bayesian Meta-Analysis of Photogrammetric StudiesYi Feng Wen, Hai Ming Wong, Ruitao Lin, et al.
Statistics in Medicine|April 20, 2026
BAR12: Bayesian Autoregressive Phase 1-2 Design for Cell Therapy Trials With Manufacturing ChangesCheng-Han Yang, Peter F Thall, David Marin, et al.
The Annals of Applied Statistics|November 4, 2022
BAYESIAN HIERARCHICAL RANDOM-EFFECTS META-ANALYSIS AND DESIGN OF PHASE I CLINICAL TRIALSRuitao Lin, Haolun Shi, Guosheng Yin, et al.
Statistics in Medicine|January 31, 2022
TITE-BOIN12: A Bayesian phase I/II trial design to find the optimal biological dose with late-onset toxicity and efficacyYanhong Zhou, Ruitao Lin, J Jack Lee, et al.
Frontiers in Oncology|June 20, 2019
Trends and Patterns of Disparities in Burden of Lung Cancer in the United States, 1974-2015Yu Jie Zhong, Yi Feng Wen, Hai Ming Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2023
Novel Clinical Trial Designs with Dose Optimization to Improve Long-term OutcomesPeter F Thall, Yong Zang, Andrew G Chapple, et al.
Statistics in Medicine|May 20, 2025
TODO: A Triple-Outcome Double-Criterion Optimal Design for Dose Monitoring-and-Optimization in Multi-Dose Randomized TrialsJingyi Zhang, Heng Zhou, Nolan A Wages, et al.
Journal of Hematology & Oncology|June 10, 2021
The global, regional, and national burden of cancer among adolescents and young adults in 204 countries and territories, 1990-2019: a population-based studyYi Feng Wen, Meng Xuan Chen, Guosheng Yin, et al.
Joint Commission Journal on Quality and Patient Safety|May 22, 2026
Association of Timing of Psychiatry Consultation and Length of Stay and Length of Stay Index in Hospitalized Patients with Cancer: Risk-Adjusted OutcomesDeepti Chopra, Noman Ali, Kodwo Dickson, et al.
Pageof 10